Archive | Health Professionals

VIDEO: Speaker compares single-agent vs. combination immunotherapy for melanoma

Source: Healio, April 2017 NEW YORK — Mario Sznol, MD, professor of medicine at Yale Cancer Center, discusses whether single-agent or combination immunotherapy should be used to treat patients with melanoma at HemOnc Today Melanoma and Cutaneous Malignancies. A retrospective review demonstrated single-agent anti–PD-1 therapies produced durable responses with good tolerability, although combination therapies yielded […]

Read the full story

Posted in Melanoma In The News, OncLive Videos

CheckMate 067 Shows OS Improved With Nivolumab/Ipilimumab in Melanoma

A nivolumab/ipilimumab combination and nivolumab alone significantly improved overall survival (OS) compared with ipilimumab alone for advanced melanoma patients, according to a new study.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Dermoscopic Evaluation of Seborrheic Keratosis Can Help Diagnose Melanoma

A new study has identified several characteristics that can help to detect seborrheic keratosis (SK)–like melanomas using dermoscopy, including the presence of the blue-black sign, pigment network, pseudopods or streaks, and/or a blue-white veil.

Read the full story

Posted in Melanoma In The News, Information

Assessment of Melanoma Screening Practices Produces Data-Driven, Risk-Based Guidelines

More than 50 dermatologists assessed screening practices for melanoma in a perspective study published recently in Melanoma Management that aimed to address the fact that currently no national consensus exists on skin cancer screening in the United States.

Read the full story

Posted in Melanoma In The News, Information

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories